Since previous studies with TS-overexpressing colon cancer cells showed that elevated TYMS was associated with 5-FU resistance [36], but retained sensitivity to polymeric fluoropyrimidines (e.g., F10 [19]), we also tested CF10 in our SCLC PDO models. This evidence concerns the gene TYMS and malignant colon neoplasm.